Salvage HDR for Locally Recurrent Prostate Cancer
The study offers focal salvage brachytherapy for prostate cancer patients with a local recurrence after primary defintive radiotherapy
Trial Details
- NCT ID
- NCT04231006
- Phase
- NA
- Sponsor
- Aarhus University Hospital
- Status
- RECRUITING
- Cancer Type
- Prostate Cancer
- Interventions
- High dose rate brachytherapy
- Locations (sample)
- Aarhus, Region Midt, Denmark|56.15674,10.21076
Key Eligibility Criteria
- Man ≥ 18 years, who had definitive EBRT or BT for prostate cancer T1-3b, N0-1, M0
- ≥ 2 years since the end of primary radiotherapy
- PSA recurrence Phoenix criteria (nadir + 2)
- No evidence of regional lymph nodes or distant metastases on PSMA PET/CT
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Prostate Cancer Trials on Trialify →